Coverage Policies

Important! Please note:

Current policies effective through April 30, 2024.

Use the index below to search for coverage information on specific medical conditions.

High-Tech Imaging: High-Tech Imaging services are administered by National Imaging Associates, Inc. (NIA). For coverage information and authorizations, click here.

Medical Providers: Payment for care or services is based on eligibility, medical necessity and available benefits at time of service and is subject to all contractual exclusions and limitations, including pre-existing conditions if applicable.

Future eligibility cannot be guaranteed and should be rechecked at time of service. Verify benefits by signing into My Account or calling Customer Service at 800.235.7111 or 501.228.7111.

QualChoice follows care guidelines published by MCG Health.

Clinical Practice Guidelines for Providers (PDF)

QualChoice reserves the right to alter, amend, change or supplement medical policies as needed. QualChoice reviews and authorizes services and substances. CPT and HCPCS codes are listed as a convenience and any absent, new or changed codes do not alter the intent of the policy.

INDEX:
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

Effective Date: 10/05/2002 Title: Electrodiagnostic Testing
Revision Date: 11/01/2017 Document: BI007:00
CPT Code(s): 95860-95872, 95900-95904 , 95933-95937, S3900 and S3905
Public Statement

Effective Date:

a)    This policy will apply to all services performed on or after the above revision date which will become the new effective date.

b)    For all services referred to in this policy that were performed before the revision date, contact customer service for the rules that would apply.

1)    Electro-Diagnostic testing is generally covered.

2)    Electro-Diagnostic Testing includes:

a)    Nerve Conduction Studies (NCS) test the peripheral nervous system for:

i)       Integrity, and

ii)     Diagnosis of diseases of the nerves.

b)    Electromyography (EMG) is the study and recording of the electrical properties of skeletal muscles. This is done to test for diseases in the muscles or the nerves leading to those muscles – usually in cases of weakness. This is carried out with a needle electrode.

3)    These services may be performed in the physician’s office and may be subject to deductible and coinsurance.

4)    Nerve Conduction Study and EMG performed by Occupational/Physical Therapists are covered only if they are rendered by a therapist who has had special training in performing this type of testing.  Reimbursement to the therapist is limited to the technical component of the procedure only.  In order for the technical component of the test to be reimbursed to the therapist the NCS must be:

a)    Ordered by a physician;

b)    Performed under the supervision of a physician; and

c)     Interpreted by a qualified physician with training in the interpretation of nerve conduction studies.


Medical Statement

1)    Nerve conduction studies (NCS) are considered medically necessary in either of the following indications: 

a)    For diagnosis of peripheral nerve diseases; OR

b)    For differential diagnosis of symptom-based complaints (e.g., pain in limb, weakness, disturbance in skin sensation or paresthesia) provided the clinical assessment supports the need for a study.

2)    Repetitive nerve stimulation testing is considered medically necessary for the diagnosis of neuromuscular junction disorders (e.g., myasthenia gravis, myasthenic syndrome).

3)    Nerve conduction studies have been found to be medically necessary for the following conditions:

a)    Carpal tunnel syndrome (see selection criteria below), or other compressive mononeuropathy

b)    Diabetic neuropathy

c)     Disorders of peripheral nervous system

d)    Disturbance of skin sensation

e)    Fasciculation

f)      Joint pain

g)    Muscle weakness

h)    Myopathy

i)       Myositis

j)      Nerve root compression

k)     Neuritis

l)       Neuromuscular conditions

m)  Pain in limb

n)    Plexopathy

o)    Spinal cord injury

p)    Swelling and cramps

q)    Trauma to nerves

4)    For evaluation of individuals suspected of having unilateral carpal tunnel syndrome, the following services are considered  medically necessary: 

a)    Sensory conduction studies of the median nerve and one other sensory nerve in the symptomatic limb; AND

b)    Motor conduction studies of the median nerve recording from the thenar muscles and of one other nerve in the symptomatic limb to include measurement of distal latencies; AND

c)     If one of the studies of the median nerve is abnormal, F wave testing of the median nerve to assess proximal function; AND

d)    If one of the studies of the median nerve is abnormal, a test of the contralateral median nerve to assess for bilaterality.

5)    Blink reflex testing is considered medically necessary to evaluate disease involving the 5th or 7th cranial nerves or brainstem. Blink reflexes are considered experimental and investigational for all other indications.

Codes Used In This BI:

95860

Muscle test one limb

95861

Muscle test 2 limbs

95863

Muscle test 3 limbs

95864

Muscle test 4 limbs

95865

Muscle test larynx

95866

Muscle test hemi diaphragm

95867

Muscle test cran nerv unilat

95868

Muscle test cran nerve bilat

95869

Muscle test thor paraspinal

95870

Muscle test nonparaspinal

95872

Muscle test one fiber

95907

Nerve Conduction Study

95908

Nerve Conduction Study

95909

Nerve Conduction Study

95910

Nerve Conduction Study

95911

Nerve Conduction Study

95912

Nerve Conduction Study

95913

Nerve Conduction Study

95933

Blink reflex test

95937

Neuromuscular junction test

S3900

Surface EMG


Limits

1)    Quantitative sensory testing (QST) (0106T – 0110T) is considered experimental/investigational for the management of individuals with neuropathy or any other diagnoses because its diagnostic value has not been established.

2)    Current Perception Threshold (CPT) (no CPT or HCPCS codes found) testing is considered experimental/investigational because the effectiveness and clinical applicability of this testing in diagnosing and/or managing diabetic peripheral neuropathy or other diseases has not been established.

3)    Voltage-actuated sensory nerve conduction threshold (VsNCT) testing is considered experimental/investigational because its clinical value has not been established in the peer reviewed published medical literature.

4)    Surface scanning electromyography (EMG), paraspinal surface EMG, or macro EMG is considered experimental/investigational as a diagnostic test for evaluating low back pain or other thoracolumbar segmental abnormalities such as soft tissue injury, intervertebral disc disease, nerve root irritation and scoliosis, and for all other indications because the reliability and validity of these tests have not been established. HAYES D

5)    Portable surface EMG devices are considered experimental/investigational for diagnosis and/or monitoring of nocturnal bruxism and all other indications because the reliability and validity of these tests have not been demonstrated.

6)    Spinoscopy (Spinoscope, Spinex Corp.), a diagnostic technique that combines surface scanning EMG with video recordings, is considered experimental/investigational as the clinical value of this diagnostic technique has not been validated.

7)    F-wave study to evaluate the median nerve at the carpal tunnel in carpal tunnel syndrome is considered experimental/investigational since there is no proven value to this study for this condition. F-wave study for testing the proximal median nerve to assess proximal function in the presence of abnormality at the carpal tunnel is appropriate.

8)    Examination/NCS studies using the NC-stat monitor, the Brevio NCS monitor, the Neural-Scan, and other automated portable hand-held devices are considered experimental/investigational.

9)    NCS studies are considered experimental/investigational for screening for polyneuropathy of diabetes or end-stage renal disease. [in asymptomatic individuals]

10) NCS studies are considered experimental/investigational for the sole purpose of monitoring disease intensity or treatment effectiveness for polyneuropathy of diabetes or end-stage renal disease.

11) EMG by other than needle is considered experimental/investigational.


Background

1)    Electrodiagnostic testing should be performed by a physician with specific training in the conduct and interpretation of the tests. These tests should be conducted and interpreted in a face to face encounter11.

2)    Number of tests to be performed14:
The following table lists the American Association of Electrodiagnostic Medicine`s  recommendations concerning a reasonable maximum number of NCS, needle EMG and other electrodiagnostic studies per diagnostic category needed for a physician to render a diagnosis:

Electro-diagnostic Testing Chart

 

Needle Electromyography

Nerve Conduction Studies

Other Electromyographic Studies

Indications

Number of Tests

Motor NCS with and/or without   F wave

Sensory NCS

H-Reflex

Neuromuscular Junction Testing (Repetitive Stimulation)

Carpal Tunnel Unilateral

1

3

4

 

 

Carpal Tunnel Bilateral

2

4

4

 

 

Radiculopathy

2

3

2

2

 

Mononeuropathy

1

3

3

2

 

Polyneuropathy/ Mononeuropathy Multiplex

3

4

4

2

 

Myopathy

2

2

2

 

2

Plexopathy

2

4

6

2

 

Neuromuscular Junction

2

2

2

 

3

Tarsal Tunnel Syndrome (Uni)

1

4

4

 

 

Tarsal Tunnel Syndrome (Bil)

2

5

6

 

 

Weakness, Fatigue, Cramps or Twitching (Focal)

2

3

4

 

2

Weakness, Fatigue, Cramps, or Twitching (General)

4

4

4

 

2

Pain, Numbness, or Tingling (Uni)

1

3

4

2

 

Pain, Numbness, or Tingling (Bil)

2

4

6

2

 

Utilization of motor or sensory nerve conduction studies at a frequency of 2 sessions per year would be considered appropriate for most conditions (e.g., unilateral or bilateral carpal tunnel syndrome, radiculopathy, mononeuropathy, polyneuropathy, myopathy, and neuromuscular junction disorders). Nerve conduction studies performed more frequently than twice a year may be reviewed for medical necessity. 

  • Motor and sensory nerve conduction studies and late responses (F-wave and H-reflex studies) are often complementary and performed during the same evaluation.  
  • F-wave and H-reflex studies are performed to evaluate nerve conduction in portions of the nerve more proximal (near the spine) and, therefore, inaccessible to direct assessment using conventional techniques.  Electrical stimulation is applied on the skin surface near a nerve site in a manner that sends impulses both proximally and distally.  Characteristics of the responses are assessed, including latency.  Late responses provide information in the evaluation of radiculopathies, plexopathies, polyneuropathies (especially in suspected Guillain-Barré syndrome or chronic inflammatory demyelinating polyneuropathy), and proximal mononeuropathies.  In some cases, they may be the only abnormal study.

H-Reflex Studies

  • Typically, only 2 H-reflex studies are performed in a given examination.
  • H-reflex studies usually must be performed bilaterally because symmetry of responses is an important criterion for abnormality.  When a bilateral H-reflex study is performed, the entire procedure must be repeated, increasing examiner time and effort; there are no economies of scale in multiple H-reflex testing.
  • H-reflex studies usually involve assessment of the gastrocnemius/soleus muscle complex in the calf.  Bilateral gastrocnemius/soleus H-reflex abnormalities are often early indications of spinal stenosis, or bilateral S1 radiculopathies.
  • In rare instances, H reflexes need to be tested in muscles other than the gastrocnemius/soleus muscle, e.g., in the upper limbs.   In conditions such as cervical radiculopathies or brachial plexopathies, an H-reflex study can be performed in the arm (flexor carpi radialis muscle).  Other muscles that may be tested, although rarely, are the intrinsic small muscles of the hand and foot.

F-Wave Studies

  • Although the set-up for an F-wave study is similar to the set-up for a motor NCS, the testing is carried out separately from the motor NCS, utilizing different machine settings and separate stimuli. A large number of responses (at least 10) are obtained.
  • The number of F-wave studies, which need to be performed on a given person, depends on the working diagnosis and the electrodiagnostic findings already in evidence.  It may be appropriate in the same person to perform some motor NCS with an F-wave and others without an F-wave.

Reference
  1. Garssen MP, Blok JH, van Doorn PA, Visser GH. Conduction velocity distribution in neurologically well-recovered but fatigued Guillain-Barre syndrome patients. Muscle Nerve. 2006; 33(2):177-182.
  2. Leffler CT, Gozani SN, Cros D. Median neuropathy at the wrist: Diagnostic utility of clinical findings and an automated electrodiagnostic device. J Occup Environ Med. 2000; 42(4):398-409.
  3. Vinik AI, Emley MS, Megerian JT, Gozani SN. Median and ulnar nerve conduction measurements in patients with symptoms of diabetic peripheral neuropathy using the NC-stat system. Diabetes Technol Ther. 2004; 6(6):816-284.
  4. Elkowitz SJ, Dubin NH, Richards BE, Wilgis EF. Clinical utility of portable versus traditional electrodiagnostic testing for diagnosing, evaluating, and treating carpal tunnel syndrome. Am J Orthop. 2005; 34(8):362-364.
  5. Kong X, Gozani SN, Hayes MT, Weinberg DH. NC-stat sensory nerve conduction studies in the median and ulnar nerves of symptomatic patients. Clin Neurophysiol. 2006; 117(2):405-413.
  6. Megerian JT, Gozani SN. Upper extremity nerve conduction studies in diabetic patients with the NC-stat. Diabetes Technol Ther. 2006; 8(2):258-260.
  7. Katz RT. NC-stat as a screening tool for carpal tunnel syndrome in industrial workers. J Occup Environ Med. 2006; 48(4):414-418.
  8. Marciniak C, Armon C, Wilson J, Miller R. Practice parameter: Utility of electrodiagnostic techniques in evaluating patients with suspected peroneal neuropathy. An evidence-based review. Muscle Nerve. 2005; 31(4):520-527.
  9. Patel AT, Gaines K, Malamut R, et al. Usefulness of electrodiagnostic techniques in the evaluation of suspected tarsal tunnel syndrome: An evidence-based review. Muscle Nerve. 2005; 32(2):236-240.
  10. American Association of Neuromuscular & Electrodiagnostic Medicine (AANEM). Proper performance and interpretation of electrodiagnostic studies. Muscle Nerve. 2006; 33(3):436-439. Available at: http://www.aanem.org/documents/ProperPerformance.pdf
  11. Garssen MP, van Doorn PA, Visser GH. Nerve conduction studies in relation to residual fatigue in Guillain-Barré syndrome. J Neurol. 2006; 253(7):851-856.
  12. Work Loss Data Institute. Carpal tunnel syndrome (acute & chronic). Corpus Christi, TX: Work Loss Data Institute; 2006.
  13. American Medical Association (AMA). Appendix J -- Electrodiagnostic medicine listing of sensory, motor, and mixed nerves. Current Procedural Terminology (CPT) 2007. Professional ed. Chicago, IL: AMA; 2007: 499.

Addendum:

  • Effective 11/01/2016: Added specified reimbursement criteria for Physical and Occupational therapists, performing the study.
  • Effective 11/01/2017: Inclusion of other compressive mononeuropathies (in addition to carpal tunnel syndrome)

Application to Products

This policy applies to all health plans and products administered by QualChoice, both those insured by QualChoice and those that are self-funded by the sponsoring employer, unless there is indication in this policy otherwise or a stated exclusion in your medical plan booklet.  Consult the individual plan sponsor Summary Plan Description (SPD) for self-insured plans or the specific Evidence of Coverage (EOC) or Certificate of Coverage (COC) for those plans or products insured by QualChoice.  In the event of a discrepancy between this policy and a self-insured customer’s SPD or the specific QualChoice EOC or COC, the SPD, EOC, or COC, as applicable, will prevail.  State and federal mandates will be followed as they apply.


Changes: QualChoice reserves the right to alter, amend, change or supplement benefit interpretations as needed.
This policy has recently been updated. Please use the index above or enter policy title in search bar for the latest version.